260 results match your criteria: "Osaka Toneyama Medical Center[Affiliation]"

We report a case of argyrophilic grain disease (AGD) with unique clinical and pathological presentations. A 52-year-old man presented with spastic quadriparesis, bulbar palsy, and mild cognitive decline. His condition deteriorated rapidly and he died of pneumonia three years from onset.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates the clinical aspects of Becker muscular dystrophy (BMD), a milder form of Duchenne muscular dystrophy (DMD), focusing on muscle, respiratory, cardiac, and central nervous system involvement in 225 patients.
  • - Most patients presented initial muscular symptoms, with gait disturbances noted in over half, and a small percentage requiring ventilators or showing heart complications, with specific genotype correlations found.
  • - The findings are significant for guiding treatment and preventive measures for BMD, offering crucial insights for both patients and healthcare professionals.
View Article and Find Full Text PDF

Amikacin liposome inhalation suspension (ALIS) is a key drug for the treatment of refractory complex pulmonary disease (MAC-PD). Although cases of drug-induced interstitial lung disease (DIILD) by ALIS have been reported, its diagnosis is challenging due to overlapping existing pulmonary shadows, airway bleeding, exacerbation of underlying conditions, and the potential for various concurrent infections. A 72-year-old woman started treatment with ALIS for refractory MAC-PD.

View Article and Find Full Text PDF
Article Synopsis
  • * Imaging studies show significant white matter defects in DM1 patients, prompting research into abnormal RNA splicing in both gray and white matter of the brain.
  • * The study found splicing abnormalities in several genes common to both gray and white matter, suggesting that defects in glial cells like astrocytes and oligodendrocytes might contribute to white matter issues in DM1.
View Article and Find Full Text PDF

Introduction: Stage classification is an important underpinning of management in patients with cancer and rests on a combination of three components-T for tumor extent, N for nodal involvement, and M for distant metastases. This article details the revision of the N and the M components of thymic epithelial tumors for the ninth edition of the TNM classification of malignant tumors proposed by the Thymic Domain of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee.

Methods: The N and M components of the eighth edition staging system were verified by a large international collaborative data source through a data-driven analysis.

View Article and Find Full Text PDF

Introduction: In 2014, a TNM-based system for thymic epithelial tumors was proposed. The TNM stage classification system was published as a result of a joint project from the International Association for the Study of Lung Cancer and the International Thymic Malignancy Interest Group for the eighth edition of the American Joint Commission on Cancer and the Union for International Cancer Control stage classification system. The Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer received the mandate to make proposals for the ninth edition of the TNM stage classification.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates expiratory pressure load training (EPT) as a method to improve exercise intolerance in patients with chronic obstructive pulmonary disease (COPD) by targeting laryngeal narrowing.
  • In a trial involving 47 COPD patients, those undergoing EPT showed significant improvements in endurance time and peak oxygen uptake compared to control groups.
  • The findings suggest that EPT enhances aerobic capacity, increases laryngeal widening, and improves ventilation, even in advanced stages of COPD.
View Article and Find Full Text PDF

Introduction: A TNM-based system for all types of thymic epithelial tumors was introduced in the eighth edition of the TNM classification of thoracic malignancies. The Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer, composed of multispecialty international experts, was charged to develop proposals for the ninth edition. This article outlines the proposed definitions for the T, the N, and the M components and their combination into stage groups.

View Article and Find Full Text PDF

Introduction: A lymph node map is the pillar on which accurate assignment and documentation of nodal classification stands. The International Thymic Malignancy Interest Group created the first map for thymic epithelial malignancies in conjunction with the eighth edition of the TNM classification, representing the first official TNM classification of thymic epithelial malignancies. The map was based on clinical experience and published studies, but it was largely empirical because of limited available data.

View Article and Find Full Text PDF

A 69-year-old man began to experience difficulty with walking at the age of 5 years and started use of a cane at around 13 years, then finally started using a wheelchair at 17 years old. A diagnosis of Charcot-Marie-Tooth disease was previously determined at another hospital, though neither peripheral nerve biopsy nor gene analysis was conducted. He visited our institution at the age of 54 years and irregular outpatient examinations were started, which indicated slowly progressive muscle weakness and sensory disturbance of the limbs, leading to a decline in activities of daily living.

View Article and Find Full Text PDF

In July 2020, The Special Committee for Measures Against Transition from Pediatric to Adult Health Care of the Japanese Society of Neurology was established to address transitional care for patients with childhood-onset neurological disorders. One of the measures used was a questionnaire regarding transitional medicine given to the 129 board members in the Kinki area. Of the 46 respondents, 42 answered that they would "generally examine such patients" or "judge on a case-by-case basis" for patients referred from a pediatric physician.

View Article and Find Full Text PDF

Introduction: A TNM-based stage classification system of thymic epithelial tumors was adopted for the eighth edition of the stage classification of malignant tumors. The Thymic Domain of the Staging and Prognostics Factor Committee of the International Association for the Study of Lung Cancer developed a new database with the purpose to make proposals for the ninth edition stage classification system. This article outlines the proposed definitions for the T categories for the ninth edition TNM stage classification of thymic malignancies.

View Article and Find Full Text PDF

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

Sci Rep

August 2023

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Tetracyclines exhibit anti-viral, anti-inflammatory, and immunomodulatory activities via various mechanisms. The present study investigated the efficacy and safety of demeclocycline in patients hospitalized with mild-to-moderate COVID-19 via an open-label, multicenter, parallel-group, randomized controlled phase 2 trial. Primary and secondary outcomes included changes from baseline (day 1, before the study treatment) in lymphocytes, cytokines, and SARS-CoV-2 RNA on day 8.

View Article and Find Full Text PDF

Background: Myotonic dystrophy type 1 (DM1) is a form of muscular dystrophy that causes various symptoms, including those of the central nervous system. Some studies have reported cognitive decline in patients with DM1, although the available evidence is limited.

Objective: This study aimed to describe longitudinal differences in neuropsychological function in patients with DM1.

View Article and Find Full Text PDF

Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment.

Int J Mol Sci

July 2023

Organization for Research Initiative and Promotion, Research Initiative Center, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.

Article Synopsis
  • - Spinal muscular atrophy (SMA) is a genetic lower motor neuron disease, first reported in 1891, that is inherited in an autosomal recessive manner, with the genetic cause identified in 1995.
  • - SMA affects approximately 1 in 10,000 to 20,000 live births, and over 95% of affected individuals have a specific gene deletion associated with the condition.
  • - Recent advancements include the approval of three treatments for SMA, with promising clinical trials showing that early detection and treatment can help pre-symptomatic patients achieve key developmental milestones.
View Article and Find Full Text PDF

Objective: To investigate the efficacy of basic fibroblast growth factor (bFGF) in promoting meniscus regeneration by cultivating synovial mesenchymal stem cells (SMSCs) and to validate the underlying mechanisms.

Methods: Human SMSCs were collected from patients with osteoarthritis. Eight-week-old nude rats underwent hemi-meniscectomy, and SMSCs in pellet form, either with or without bFGF (1.

View Article and Find Full Text PDF

Genetic Creutzfeldt-Jakob disease (gCJD) with V180I prion protein gene (PRNP) mutation shows weaker prion protein (PrP) deposition histologically compared with sporadic CJD, and it is more difficult to detect protease-resistant prion protein in immunoblotting. However, we previously reported the autopsy case of a patient with V180I gCJD who was treated with pentosan polysulfate sodium (PPS); this case had increased protease-resistant PrP deposition. It has been suggested that PPS might reduce protease-resistant PrP; however, the detailed pharmacological and histopathological effects of PPS in humans remain unknown.

View Article and Find Full Text PDF

Purpose: Patients with a thymic epithelial tumor (TET), comprising thymoma, thymic carcinoma (TC), and thymic neuroendocrine neoplasm (TNEN), are rarely encountered. The present study was conducted to determine the recent outcomes of surgical treatment for TET in Japan and clarify the significance of prognostic factors by analyzing a nationwide database created by the Japanese Association for Research on the Thymus (JART).

Methods: The JART database includes records of 2471 thymoma, 285 TC, and 56 TNEN cases surgically treated between 1991 and 2010.

View Article and Find Full Text PDF

Objectives: To evaluate the impact of the COVID-19 pandemic on outpatient care in Japanese patients with neuromuscular diseases (NMDs).

Design: This retrospective cohort study included patients between January 2018 and February 2019; the follow-up period was divided into 'before COVID-19' (March 2019-February 2020) and 'during COVID-19' (March 2020-February 2021).

Setting: JMDC claims database study.

View Article and Find Full Text PDF

Objective Skeletal muscle weakness and cardiomyopathy can be seen in carriers of dystrophinopathy. Therefore, the health management of caregivers of Duchenne/Becker muscular dystrophy (DMD/BMD) patients who are themselves carriers is an important issue. However, few studies have focused on caregivers who have dystrophin mutations.

View Article and Find Full Text PDF

Background: Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has limited treatment options for patients with EGFR-mutated non-small-cell lung cancer (NSCLC). Although osimertinib or afatinib alone induced drug-resistant clones with EGFR secondary mutation in a preclinical model, its combination prevented the appearance of these mutations. We investigated alternating-dose therapy of osimertinib and afatinib in patients with EGFR-mutant NSCLC in a single-arm Phase II trial.

View Article and Find Full Text PDF
Article Synopsis
  • Zoledronic acid (ZA) is effective in reducing skeletal-related events (SREs) in lung cancer patients with bone metastases, but the ideal dosing interval remains unclear.
  • A randomized trial compared 4 mg of ZA given every four weeks versus every eight weeks, assessing the time to first SRE and other health indicators over one year.
  • Results showed no significant differences in SRE occurrence or other health measures between the two dosing groups, suggesting an eight-week interval is a safe and viable option for treatment.
View Article and Find Full Text PDF

Introduction: Durvalumab maintenance therapy after definitive concurrent chemoradiotherapy (CRT) is the standard treatment modality for stage III NSCLC. Although severe treatment-related lymphopenia (TRL) during CRT may impair the efficacy of subsequent durvalumab therapy, data on the effect of TRL recovery on consolidation durvalumab therapy are lacking.

Methods: This retrospective study evaluated patients with unresectable stage III NSCLC treated with durvalumab after concurrent CRT.

View Article and Find Full Text PDF

Background: According to the conventional postoperative procedure after total ankle arthroplasty (TAA), mobilization is currently started after completion of wound healing. To investigate the possibility of expediting rehabilitation, this study evaluated the feasibility and safety of early mobilization of dorsiflexion after cemented TAA utilizing a modified antero-lateral approach.

Materials And Methods: This retrospective, observational study investigated 14 consecutive ankles that had received cemented TAA.

View Article and Find Full Text PDF